ArticleVaccines2024

Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs.

Bianca L Artiaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.